Health
newsGP – AstraZeneca’s lower efficacy has been questioned, but what about other considerations? – RACGP
Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.
News
Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.
The spotlight is on AstraZenecas candidate, co-developed with the University of Oxford, as Australia moves closer to its mid-February vaccine rollout.
As the US, UK and Europe continue to record thousands of daily new cases of COVID-19, it has been said time again that Australia is in an enviable position.The vaccine roadmap is expected to begin with…
Continue Reading